Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Deininger

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
Resistance and relapse with imatinib in CML: causes and consequencesMichael Deininger
Nature Genetics|May 1, 2004
Src kinases in Ph+ lymphoblastic leukemiaMichael Deininger
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
The current status of ponatinib in the treatment of chronic myeloid leukemiaMichael Deininger
Nature Reviews. Clinical Oncology|February 2, 2011
Hematology: curing CML with imatinib--a dream come true?Michael Deininger
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Resistance to imatinib: mechanisms and managementMichael Deininger
Clinical Advances in Hematology & Oncology : H&O|April 20, 2010
Chronic myelogenous leukemia therapy beyond imatinibMichael Deininger
Leukemia & Lymphoma|April 10, 2008
Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemiaPeter Valent, Michael Deininger
Drugs|December 5, 2024
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment SituationsEhab Atallah, Michael Deininger
Leukemia & Lymphoma|February 9, 2011
Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemiaBirgitta Mitchell, Michael Deininger
Leukemia & Lymphoma|October 30, 2004
Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinibMarc Loriaux, Michael Deininger
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
Resistance and relapse with imatinib in CML: causes and consequencesMichael Deininger
Nature Genetics|May 1, 2004
Src kinases in Ph+ lymphoblastic leukemiaMichael Deininger
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
The current status of ponatinib in the treatment of chronic myeloid leukemiaMichael Deininger
Nature Reviews. Clinical Oncology|February 2, 2011
Hematology: curing CML with imatinib--a dream come true?Michael Deininger
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Resistance to imatinib: mechanisms and managementMichael Deininger
Clinical Advances in Hematology & Oncology : H&O|April 20, 2010
Chronic myelogenous leukemia therapy beyond imatinibMichael Deininger
Leukemia & Lymphoma|April 10, 2008
Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemiaPeter Valent, Michael Deininger
Drugs|December 5, 2024
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment SituationsEhab Atallah, Michael Deininger
Leukemia & Lymphoma|February 9, 2011
Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemiaBirgitta Mitchell, Michael Deininger
Leukemia & Lymphoma|October 30, 2004
Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinibMarc Loriaux, Michael Deininger
Pageof 8